Trials / Completed
CompletedNCT01885130
Patch Test Skin Irritation/Sensitization of Cetaphil Daily Advance Ultra Hydration Lotion
100 Human Subject Repeat Insult Patch Test Skin Irritation/Sensitization Evaluation (Occlusive Patch)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Determine if Cetaphil Daily Advance Ultra Hydrating Lotion proves to be a contact sensitizer or irritant in certain individuals.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cetaphil Daily Advance Ultra Hydrating Lotion | 0.2ml or 0.2g of Cetaphil on occlusive, hypoallergenic patch applied to skin for 24 hrs 9 times on Monday, Wednesday, and Friday for 3 weeks |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2013-01-01
- First posted
- 2013-06-24
- Last updated
- 2022-07-29
Source: ClinicalTrials.gov record NCT01885130. Inclusion in this directory is not an endorsement.